New Test that Indicates Likelihood of Lupus Disease Flares is Now Available

A new test has been developed that can assess the likelihood of experiencing a lupus disease flare in the following three months or 12 weeks. The aiSLE™ DX Flare Risk Index is a blood test that measures blood changes against a set of laboratory blood-based biomarkers. If a person with lupus has a positive odds ratio, they are five times more likely to experience a disease flare than a healthy patient.

The test has the potential to help rheumatologists better manage lupus symptoms in people with the disease. To learn more about the test and how the test can help in your personal lupus disease management, please consult with your doctor. Learn about lab tests for lupus.